These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12706322)

  • 1. Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects.
    Ahmad J; Shafique S; Abidi SM; Parwez I
    Diabetes Res Clin Pract; 2003 May; 60(2):131-8. PubMed ID: 12706322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: a 3-year placebo-controlled biopsy study.
    Nankervis A; Nicholls K; Kilmartin G; Allen P; Ratnaike S; Martin FI
    Metabolism; 1998 Dec; 47(12 Suppl 1):12-5. PubMed ID: 9867064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
    Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
    Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
    Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Ravid M; Brosh D; Levi Z; Bar-Dayan Y; Ravid D; Rachmani R
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):982-8. PubMed ID: 9625684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.
    Rudberg S; Osterby R; Bangstad HJ; Dahlquist G; Persson B
    Diabetologia; 1999 May; 42(5):589-95. PubMed ID: 10333052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.
    Drummond K; Mauer M;
    Diabetes; 2002 May; 51(5):1580-7. PubMed ID: 11978659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
    Mauer M; Zinman B; Gardiner R; Suissa S; Sinaiko A; Strand T; Drummond K; Donnelly S; Goodyer P; Gubler MC; Klein R
    N Engl J Med; 2009 Jul; 361(1):40-51. PubMed ID: 19571282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM; McGill JB; Gans DJ
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
    Marre M; Chatellier G; Leblanc H; Guyene TT; Menard J; Passa P
    BMJ; 1988 Oct; 297(6656):1092-5. PubMed ID: 2848604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
    Hoogenberg K; Navis G; Dullaart RP
    Nephrol Dial Transplant; 1998 Mar; 13(3):640-5. PubMed ID: 9550640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression.
    Fioretto P; Steffes MW; Sutherland DE; Mauer M
    Kidney Int; 1995 Dec; 48(6):1929-35. PubMed ID: 8587254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
    Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
    Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up study of glomerular dimensions and cortical interstitium in microalbuminuric type 1 diabetic patients with or without antihypertensive treatment.
    Osterby R; Bangstad HJ; Rudberg S
    Nephrol Dial Transplant; 2000 Oct; 15(10):1609-16. PubMed ID: 11007830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
    J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.
    Mogensen CE; Viberti G; Halimi S; Ritz E; Ruilope L; Jermendy G; Widimsky J; Sareli P; Taton J; Rull J; Erdogan G; De Leeuw PW; Ribeiro A; Sanchez R; Mechmeche R; Nolan J; Sirotiakova J; Hamani A; Scheen A; Hess B; Luger A; Thomas SM;
    Hypertension; 2003 May; 41(5):1063-71. PubMed ID: 12654706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes.
    Caramori ML; Kim Y; Huang C; Fish AJ; Rich SS; Miller ME; Russell G; Mauer M
    Diabetes; 2002 Feb; 51(2):506-13. PubMed ID: 11812762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.